Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study

Fig. 1

Kaplan–Meier curves for persistence for reasons other than disease progression: a dependent on adverse events within the first 30 days, b dependent on noncompliance due to illness, c dependent on noncompliance in the past 30 days. a Kaplan-Meier curves for at least one adverse event within the first 30 days after therapy start (0 = no adverse event; 1 = any adverse event). b Kaplan-Meier curves for the question „Do you not take your medicine at all if you feel worse due to illness?” (0 = False; 1 = True). c: Kaplan-Meier curves for the question „On how many days in the past 30 days did you not take/forget to take your medicine?” (0 = 0 days; 1 = 1–10 days)

Back to article page